<DOC>
	<DOCNO>NCT00004287</DOCNO>
	<brief_summary>OBJECTIVES : I. Assess safety feasibility gene transfer third generation adenovirus H5.001CBCFTR patient cystic fibrosis .</brief_summary>
	<brief_title>Phase I Study Third Generation Adenovirus H5.001CBCFTR Patients With Cystic Fibrosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : H5.001CBCFTR , adenovirus vector contain cystic fibrosis transmembrane conductance regulator gene , administer endobronchially . Cohort 2 patient receive 1 6 H5.001CBCFTR concentration . There intrapatient dose escalation .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Cystic fibrosis diagnose follow : Sweat sodium chloride great 60 mEq/L pilocarpine iontophoresis cystic fibrosis genotype Clinical manifestation Estimated 2year survival great 50 % , i.e . : FEV1 least 30 % predict PaO2 great 55 mm Hg room air PaCO2 le 50 mm Hg room air Prior/Concurrent Therapy At least 2 month since systemic glucocorticoid At least 90 day since participation investigational therapeutic study Patient Characteristics Pulmonary : No pneumothorax within 12 month No asthma allergic bronchopulmonary aspergillosis require glucocorticoid within 2 month No sputum pathogens unless sensitive least 2 antibiotic No hemoptysis 250 mL blood 24 hour within 1 year Other : No active adenoviral infection Ad5 ( similar type ) antibody seropositive No contraindication protocol participation , e.g . : Drug abuse Alcoholism Psychiatric instability Inadequate motivation Documented azoospermia ( men ) Bilateral tubal ligation hysterectomy ( woman ) Screening exam within 4 week prior registration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2000</verification_date>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>cystic fibrosis</keyword>
	<keyword>genetic disease dysmorphic syndrome</keyword>
	<keyword>rare disease</keyword>
</DOC>